RetractedArticleOncogene2014
Oncogenic targeting of BRM drives malignancy through C/EBPβ-dependent induction of α5 integrin.
L Damiano et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
10 papers cite it
this paperpooled ittrialcites it